DAVOCETICEPT
UNII DE9GN7CD21

Substance Identification & Data

This profile provides standardized clinical and technical data for Davoceticept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DE9GN7CD21.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2307144-64-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DE9GN7CD21

CAS Registry Number

2307144-64-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DAVOCETICEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174515

National Cancer Institute reference terminology for clinical and research data.

INN ID

11827

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-165

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Davoceticept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DAVOCETICEPT

Common Names & Synonyms

1-107-CD80 ANTIGEN (18-TYROSINE,26-GLUTAMIC ACID,35-ASPARTIC ACID,47-LEUCINE,68-METHIONINE,71-GLYCINE,90-GLYCINE) (HUMAN) FUSION PROTEIN WITH PEPTIDE LINKER (GSGGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (119-SERINE,133-ALANINE,134-GLUTAMIC ACID,136-ALANINE,C-TERMINAL LYSINE-CLIPPED) (HUMAN .GAMMA.1-CHAIN C-TERMINAL FRAGMENT), DIMER

DAVOCETICEPT [INN]

DAVOCETICEPT [USAN]

DAVOCETICEPT [WHO-DD]

FRAGMENT (1-107) OF HUMAN T-LYMPHOCYTE ACTIVATION ANTIGEN CD80 (CTLA-4 (CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4) COUNTERRECEPTOR B7.1) VARIANT (H18>Y, A26>E, E35>D, M47>L, V68>M, A71>G, D90>G) FUSED, VIA PEPTIDYL LINKER 108GSGGGGS114 TO HUMAN IMMUNOGLOBULIN G1 FC FRAGMENT (115-345) VARIANT (C119>S, L133>A, L134>E, G136>A, C-TERMINAL K346 DELETED), DIMER, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

Technical Codes

ALPN202

ALPN-202

External Clinical & Regulatory Resources

Previous UNIIDE99E6YD6A

Next UNIIDE9JJJ9VWL